Biopharma facility qualification ensures production environments, utility systems, and equipment meet regulations for new ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

OPKO Health is refocusing on drug development, with most pipeline assets in early stages and limited near-term catalysts.

Novo Nordisk fell sharply after the Danish drugmaker said its CagriSema experimental obesity drug failed to beat the weight loss delivered by Eli Lilly's Zepbound in a head-to-head clinical trial.

Quince Therapeutics will end the development of its lead asset, a treatment for the neurodegenerative disorder ataxia-telangiectasia, after a pivotal Phase 3 trial failed to meet its expected outcomes ...

The Covid-19 pandemic impacted virtually every industry, with healthcare arguably undergoing the most drastic transformation. Pre-pandemic, most of us never could’ve imagined routine doctor visits ...

SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...

While on Galapagos, Darwin noticed that the giant tortoises, mockingbirds, and finches he studied differed in unique ways from the species that inhabited neighboring islands. It’s been almost 200 ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...

A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...